M3 USA

Research Marketing And Advertising (RMA) Expands Marketing Services To Clinical Research Industry Nationwide

Retrieved on: 
Wednesday, January 20, 2021
Health sciences, Health, Pharmaceutical industry, Medical research, Clinical pharmacology, Clinical trial, Design of experiments, Clinical research, Clinical

RALEIGH, N.C., Jan. 20, 2021 /PRNewswire/ --After more than nine years providing marketing and recruiting services for thousands of clinical research trials, RMA is launching a new website and expanding its services to other clinical research companies nationwide.

Key Points: 
  • RALEIGH, N.C., Jan. 20, 2021 /PRNewswire/ --After more than nine years providing marketing and recruiting services for thousands of clinical research trials, RMA is launching a new website and expanding its services to other clinical research companies nationwide.
  • Since 2011, RMA has provided a variety of clinical research marketing services across a broad range of therapeutic areas.
  • "To that end, we have launched a new website to help provide a quick and easy reference and overview to clinical research organizations in need of assistance with the marketing and advertising side of the clinical research industry."
  • In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services.

M3 Recognized On Forbes Global 2000, "The World's Largest Public Companies"

Retrieved on: 
Monday, August 3, 2020

FORT WASHINGTON, Pa., Aug. 3, 2020 /PRNewswire/ --M3, a global healthcare services firm specializing in market research, clinical research, media, and recruitment, is honored to be recognized by Forbes as one of the world's leading public companies in the Forbes Global 2000 .

Key Points: 
  • FORT WASHINGTON, Pa., Aug. 3, 2020 /PRNewswire/ --M3, a global healthcare services firm specializing in market research, clinical research, media, and recruitment, is honored to be recognized by Forbes as one of the world's leading public companies in the Forbes Global 2000 .
  • M3 ranked475th in market value, with an overall rating of 1710 among the 2,000 publicly traded companies included.
  • "This ranking is recognition of the incredible growth M3 has achieved and is a testament to the passion we have to continuously build value," states Aki Tomaru, CEO of M3 USA.
  • Each award by Forbes charts the growth and innovation by M3 as a healthcare technology leader.